Why Qualys stock is sliding today: QLYS lags cybersecurity peers in late-year trade

Why Qualys stock is sliding today: QLYS lags cybersecurity peers in late-year trade

NEW YORK, December 30, 2025, 15:41 ET — Regular session

  • Qualys shares were down about 2.5% in afternoon trading, after touching a session low.
  • Cybersecurity peers were little changed, leaving QLYS as a notable underperformer in the group.
  • Investors are weighing year-end positioning and fresh Federal Reserve signals as 2026 data and policy dates come into view.

Qualys Inc shares fell 2.5% to $133.93 in afternoon trading on Tuesday, after dropping as much as 4.2% earlier in the session. The stock closed at $137.34 on Monday.

The decline landed as U.S. equities stayed range-bound in holiday-thin conditions, with technology and financial shares among the drags. “It’s just a healthy rebalancing of allocations more so than an emotionally driven sell-off,” said Mark Hackett, chief market strategist at Nationwide. Reuters

That matters for Qualys because lighter year-end liquidity can exaggerate moves in single names, especially in software stocks where positioning has been crowded at times. With few fresh company headlines, traders tend to lean harder on macro cues and sector sentiment.

Cybersecurity peers were mostly steady: CrowdStrike was up 0.1%, Palo Alto Networks added 0.1% and Fortinet slipped 0.4%. The Invesco QQQ Trust, a widely used proxy for Nasdaq-100 tech exposure, was down 0.1%.

The company’s last major update to investors came with its Nov. 4 results, when it said third-quarter revenue rose 10% to $169.9 million and issued fourth-quarter revenue guidance of $172 million to $174 million. Qualys also guided for fourth-quarter non-GAAP net income per share of $1.73 to $1.80 and lifted its full-year revenue outlook to $665.8 million to $667.8 million. Qualys

Qualys’ newsroom lists that Nov. 4 earnings release as its most recent press update, underscoring how quickly the narrative can shift from company-specific fundamentals to tape-reading in the final sessions of the year. Qualys

Non-GAAP results are adjusted figures companies use to strip out certain items they consider non-core, such as stock-based compensation and amortization. Investors often track the gap between GAAP and non-GAAP profit to judge how much earnings power depends on adjustments.

On the macro front, the Federal Reserve’s latest meeting minutes showed a more divided debate over the December rate decision, with some policymakers describing the choice as “finely balanced.” The minutes also pointed investors to a coming catch-up in U.S. data, with December jobs and consumer price reports due in early January. Reuters

The next Fed policy meeting is scheduled for Jan. 27-28, according to the central bank’s calendar. That date is now a key waypoint for markets trying to map the rate path into 2026. Federal Reserve

For Qualys, traders will be watching whether the stock can stabilize above Tuesday’s intraday low into the close, and whether it can reclaim Monday’s closing level on any bounce. Bigger swings late in the day would not be unusual in thin trading.

Investors will also keep an eye on how management’s fourth-quarter targets line up with demand signals across enterprise security spending. Subscription renewals, customer expansion and operating margin trends remain the core read-throughs when the next results arrive.

Stock Market Today

  • Two under-$10 stocks that could double in 2026: Opendoor Technologies and Sweetgreen
    December 30, 2025, 5:25 PM EST. Two under-$10 names could double in 2026: Opendoor Technologies and Sweetgreen. Through late December, Opendoor was up about 260% in 2025 after a management reshuffle and a turnaround plan aimed at break-even on adjusted net income by year-end 2026. With mortgage rates around 6% and signs housing demand could recover, the stock's upside hinges on macro strength and execution. Sweetgreen faces a tougher year, but easier year-over-year comparisons and potential improvements in same-store sales could spark a rebound if the broader economy cooperates. The prospect of a double is speculative and relies on favorable macro conditions; as of Dec. 29, 14 S&P 500 components had doubled this year.
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale
Previous Story

Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale

S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted
Next Story

S&P Global (SPGI) stock slips near $529 as Fed minutes, year-end flows keep Wall Street muted

Go toTop